10:07 :
Cepheid soars 19% on sales outlook -
BOSTON (MarketWatch) -- Shares of diagnostic-products maker Cepheid soared 19% to $40.96 in early action Friday, the day after the company released a better-than-expected quarterly earnings report and raised it 2012 financial outlook. Cepheid ...